<span id="midArticle_start"/> (Reuters) - Belgian medical diagnosticsgroup Biocartis has raised 100 million euros ($109 million) fromthe sale of shares in its initial public offering on theBrussels stock exchange, the company said on Friday.
<span id="midArticle_0"/>Biocartis, which had planned to raise between 70 and 100million euros, said it had demand from investors for 650 millioneuros.
<span id="midArticle_1"/>Trading of Biocartis on the Brussels stock exchange isexpected to start on Monday, April 27.
<span id="midArticle_2"/>Biocartis, based in the Belgian town of Mechelen, isprimarily focused on tests in oncology and infectious diseases.It employs about 200 people.
<span id="midArticle_3"/>KBC Securities acted as global coordinators of the IPO andserved as joint bookrunner with Kempen & Co and Petercam.($1 = 0.9209 euros) (Reporting by Robert-Jan Bartunek; Editing by Greg Mahlich)
<span id="midArticle_4"/>
<span id="midArticle_0"/>Biocartis, which had planned to raise between 70 and 100million euros, said it had demand from investors for 650 millioneuros.
<span id="midArticle_1"/>Trading of Biocartis on the Brussels stock exchange isexpected to start on Monday, April 27.
<span id="midArticle_2"/>Biocartis, based in the Belgian town of Mechelen, isprimarily focused on tests in oncology and infectious diseases.It employs about 200 people.
<span id="midArticle_3"/>KBC Securities acted as global coordinators of the IPO andserved as joint bookrunner with Kempen & Co and Petercam.($1 = 0.9209 euros) (Reporting by Robert-Jan Bartunek; Editing by Greg Mahlich)
<span id="midArticle_4"/>
via Smart Health Shop Forum http://ift.tt/1PxhPzo
No comments:
Post a Comment